Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itacitinib + corticosteroids in pediatric acute GVHD
NCT03721965Phase 2Terminated
- Sponsor
- Incyte
- Start
- Dec 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of itacitinib in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Incyte. Started Dec 2019; status: terminated.
02
Drugs
itacitinib
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT03721965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03721965.